Results of blood inflammatory markers are associated more strongly with toe-brachial index than with ankle-brachial index in patients with type 2 diabetes

Diabetes Care

Volumn 27, Issue 6, 2004, Pages 1381-1386

  Aso, Yoshimasa ^a   Okumura, Ki Ichi ^a   Inoue, Teruo ^a   Matsutomo, Rika ^a   Yoshida, Noboru ^a   Wakabayashi, Sadao ^a   Takebayashi, Kohzo ^a   Inukai, Toshihiko ^a  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE MARKER; ENZYME IMMUNOASSAY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNONEPHELOMETRY; INFLAMMATION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PLETHYSMOGRAPHY; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; STROKE; TOE BRACHIAL INDEX; VASCULITIS;

AGED; ANKLE JOINT; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FEMALE; FIBRINOGEN; FUNCTIONAL LATERALITY; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PLETHYSMOGRAPHY; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; TOES;

EID: 2542482157     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.6.1381     Document Type: Article

References (23)

1. McDermott MM: Ankle brachial index as a predictor of outcomes in peripheral arterial disease. J Lab Clin Med 133:33-40, 1999
2. Strandness DE Jr, Eidt JF: Peripheral vascular disease. Circulation 102 (Suppl. 4): IV46-IV51, 2000
3. Mercer KG, Berridge DC: Peripheral vascular disease and vascular reconstruction. In The Foot in Diabetes. 3rd ed. Boulton AJM, Connor H, Cavanagh PR, Eds. Chichester, U.K., John Wiley & Sons, p. 215-234, 2000
4. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, Powe NR, Siscovick D: Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study: the Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 19:538-545, 1999
5. Edmonds ME, Morrison N, Laws JW, Watkins PJ. Medial arterial calcification and diabetic neuropathy. Br Med J 284:928-930, 1982
6. Young MJ, Adams JE, Anderson GF, Boulton AJ, Cavanagh PR: Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 36:615-621, 1993
7. Orchard TJ, Strandness DE Jr: Assessment of peripheral vascular disease in diabetes: report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association, 18-20 September 1992, New Orleans, Louisiana. Circulation 88:819-828, 1993
8. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126, 1999
9. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 105:1135-1143, 2002
10. Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J 265:621-636, 1990
11. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767-1772, 2000
12. Smith EB: Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis. Clin Haematol 15:355-370, 1986
13. Ernst E, Resch KL: Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 118:956-963, 1993
14. Rifai N, Ridker PM: High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47:403-411, 2001
15. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97:425-428, 1998
16. Cortez-Cooper MY, Supak JA, Tanaka H: A new device for automatic measurements of arterial stiffness and ankle-brachial index. Am J Cardiol 91:1519-1522, 2003
17. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843, 2000
18. Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 107:391-397, 2003
19. Meijer WT, Grobbee DE, Hunink MG, Hofman A, Hoes AW: Determinants of peripheral arterial disease in the elderly: the Rotterdam study. Arch Intern Med 160:2934-2938, 2000
20. Lakatta EG, Levy D: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I. Aging arteries: a "set up" for vascular disease. Circulation 107:139-146, 2003
21. Edmonds ME: The diabetic foot: pathophysiology and treatment (Review). Clin Endocrinol Metab 15:889-916, 1986
22. Brooks B, Dean R, Patel S, Wu B, Molyneaux L, Yue DK: TBI or not TBI: that is the question: is it better to measure toe pressure than ankle pressure in diabetic patients? Diabet Med 18:528-532, 2001
23. Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest 111:1805-1812, 2003